Intra-Aortic Balloon Pumping

• 

  Subject Areas on Research

  • A Practical Approach to Mechanical Circulatory Support in Patients Undergoing Percutaneous Coronary Intervention: An Interventional Perspective. 
  • A multicenter, randomized trial of percutaneous coronary intervention versus bypass surgery in high-risk unstable angina patients. The AWESOME (Veterans Affairs Cooperative Study #385, angina with extremely serious operative mortality evaluation) investigators from the Cooperative Studies Program of the Department of Veterans Affairs. 
  • A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study. 
  • A team-based approach to patients in cardiogenic shock. 
  • Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European Society of Cardiology. 
  • Acute lower extremity ischemia after cardiac surgery. 
  • Acute myocardial infarction in a young female. 
  • Aortic counterpulsation in acute myocardial infarction: physiologically important but does the patient benefit? 
  • Aortic counterpulsation: a review of the hemodynamic effects and indications for use. 
  • Arterial diastolic pressure augmentation by intra-aortic balloon counterpulsation enhances the onset of coronary artery reperfusion by thrombolytic therapy. 
  • Assessing Consequences of Intraaortic Balloon Counterpulsation Versus Left Ventricular Assist Devices at the Time of Heart Transplantation. 
  • Associated factors and clinical outcomes in mechanical circulatory support use in patients undergoing high risk on-pump cardiac surgery: Insights from the LEVO-CTS trial. 
  • Case study: heart transplantation--increased incidence of acute rejection in female recipients. 
  • Clinical Practice Patterns in Temporary Mechanical Circulatory Support for Shock in the Critical Care Cardiology Trials Network (CCCTN) Registry. 
  • Clinical characteristics and outcomes after unplanned intraaortic balloon counterpulsation in the Counterpulsation to Reduce Infarct Size Pre-PCI Acute Myocardial Infarction trial. 
  • Clinical predictors of major infections after cardiac surgery. 
  • Comparison of outcomes after 8 vs. 9.5 French size intra-aortic balloon counterpulsation catheters based on 9,332 patients in the prospective Benchmark registry. 
  • Comparison of the use of hemodynamic support in patients ≥80 years versus patients <80 years during high-risk percutaneous coronary interventions (from the Multicenter PROTECT II Randomized Study). 
  • Concealed mechanical bradycardia: an indication for permanent pacemaker implantation. 
  • Contemporary utilization and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction: the benchmark registry. 
  • Controlling axillary intra-aortic balloon pump inflation is a viable option for turning an acute heart failure patient into a chronic one. 
  • Coronary bypass grafting after failed elective and failed emergent percutaneous angioplasty. Relative risks of emergent surgical intervention. 
  • Diagnosis and treatment of acute coronary ischemic syndromes: a update for 1995. 
  • ECMO and the Intraaortic Balloon Pump: In Search of the Ideal Mechanical Circulatory Support Device. 
  • Economic implications of the prophylactic use of intraaortic balloon counterpulsation in the setting of acute myocardial infarction. The Randomized IABP Study Group. Intraaortic Balloon Pump. 
  • Escalating and De-escalating Temporary Mechanical Circulatory Support in Cardiogenic Shock: A Scientific Statement From the American Heart Association. 
  • Evaluating the learning curve in the prospective Randomized Clinical Trial of hemodynamic support with Impella 2.5 versus Intra-Aortic Balloon Pump in patients undergoing high-risk percutaneous coronary intervention: a prespecified subanalysis of the PROTECT II study. 
  • Evidence for overturning the guidelines in cardiogenic shock. 
  • Hemodynamic effects of new intra-aortic balloon counterpulsation timing methods in patients: a multicenter evaluation. 
  • High risk percutaneous coronary intervention and intra-aortic balloon pumps: when is the safety net needed? 
  • Impact of Non-Infarct-Related Artery Disease on Infarct Size and Outcomes (from the CRISP-AMI Trial). 
  • Impact of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump on prognostically important clinical outcomes in patients undergoing high-risk percutaneous coronary intervention (from the PROTECT II randomized trial). 
  • Impella Versus Intra-Aortic Balloon Pump for High-Risk PCI: A Propensity-Adjusted Large-Scale Claims Dataset Analysis. 
  • Importance of total ischemic time and preprocedural infarct-related artery blood flow in predicting infarct size in patients with anterior wall myocardial infarction (from the CRISP-AMI Trial). 
  • Important role of mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock. 
  • Improvement in left ventricular function following higher-risk percutaneous coronary intervention in patients with ischemic cardiomyopathy. 
  • In-hospital mortality associated with the use of intra-aortic balloon counterpulsation. 
  • Increased Opportunities for Transplantation for Women in the New Heart Allocation System. 
  • Intra-Aortic Balloon Pump Use Before Left Ventricular Assist Device Implantation: Insights From the INTERMACS Registry. 
  • Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI randomized trial. 
  • Intra-aortic balloon counterpulsation in US and non-US centres: results of the Benchmark Registry. 
  • Intra-aortic balloon counterpulsation reduces mortality in large anterior myocardial infarction complicated by persistent ischaemia: a CRISP-AMI substudy. 
  • Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock. 
  • Intra-aortic balloon pump trials: questions, answers, and unresolved issues. 
  • Intra-aortic counterpulsation balloon pumps: CT appearance. 
  • Intraaortic balloon pump location and aortic dissection. 
  • Intraaortic counterpulsation balloon: radiographic considerations. 
  • Is there a role for upper-extremity intra-aortic balloon counterpulsation as a bridge-to-recovery or a bridge-to-transplant in the treatment of end-stage heart failure? 
  • Left Ventricular Support for the Management of Cardiogenic Shock: Sooner May Be Better. 
  • Left Ventricular Support. 
  • Left ventricular support systems for high-risk percutaneous coronary interventions: how can we improve outcomes for rare procedures? 
  • Letter by O'Neill and Ohman Regarding Article, "Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock: Matched-Pair IABP-SHOCK II Trial 30-Day Mortality Analysis". 
  • Maintenance of valvular integrity with Impella left heart support: Results from the multicenter PROTECT II randomized study. 
  • Management of cardiogenic shock in the setting of ST-elevation myocardial infarction: controversies and future directions. 
  • Management of cardiogenic shock. 
  • Migration of Intraaortic Balloon Pump Placed Via the Axillary Artery. 
  • Neutrophil CD11b upregulation during cardiopulmonary bypass is associated with postoperative renal injury. 
  • Obesity and Outcomes Following Cardiogenic Shock Requiring Acute Mechanical Circulatory Support. 
  • Old Device, New Tricks: Exploring Axillary Intra-Aortic Balloon Pump Use in Advanced Heart Failure. 
  • Outcomes Among Patients Transferred for Revascularization With Impella for Acute Myocardial Infarction With Cardiogenic Shock from the cVAD Registry. 
  • Performance of currently available risk models in a cohort of mechanically supported high-risk percutaneous coronary intervention--From the PROTECT II randomized trial. 
  • Predictors of inotrope use during separation from cardiopulmonary bypass. 
  • Predictors of intra-aortic balloon pump hemodynamic failure in non-acute myocardial infarction cardiogenic shock. 
  • Prognosis in cardiogenic shock after acute myocardial infarction in the interventional era. 
  • Recommendations for the use of mechanical circulatory support: device strategies and patient selection: a scientific statement from the American Heart Association. 
  • Relation between hospital intra-aortic balloon counterpulsation volume and mortality in acute myocardial infarction complicated by cardiogenic shock. 
  • Reply: Temporary Mechanical Circulatory Support as a Bridge to Transplantation: Return of the Intra-Aortic Balloon Pump. 
  • Rethinking papillary muscle resection for refractory ventricular tachycardia in the LVAD era. A case report. 
  • Severe heart failure and mechanical circulatory support. 
  • Short and long term effect of adjunctive intra-aortic balloon pump use for patients undergoing high risk reperfusion therapy: a meta-analysis of 10 international randomised trials. 
  • The Axillary Intra-Aortic Balloon Pump as a Bridge to Recovery Allows Early Ambulation in Long-Term Use: Case Series and Literature Review. 
  • The Hostile Thoracic Aorta: Management Considerations for Severe Aortic Atheroma in a Challenging Case of Coronary Artery Bypass Grafting and Mitral Valve Replacement. 
  • The ICU chest film. Cardiopulmonary monitoring and assist devices. 
  • The Value of Left Ventricular Support in Patients With Reduced Left Ventricular Function Undergoing Extensive Revascularization: An Analysis From the PROTECT-II Randomized Trial. 
  • The current practice of intra-aortic balloon counterpulsation: results from the Benchmark Registry. 
  • The effect of intra-aortic balloon counterpulsation on coronary blood flow velocity distal to coronary artery stenoses. 
  • The effect of intra-aortic balloon counterpulsation on left ventricular functional recovery early after acute myocardial infarction: a randomized experimental magnetic resonance imaging study. 
  • The impact of a failing right heart in patients supported by intra-aortic balloon counterpulsation. 
  • The relationship between immediate outcome after cardiac surgery, homogeneous cardioplegia delivery, and ejection fraction. 
  • The use of aortic counterpulsation in United States: what can we learn from administrative databases? 
  • The use of intraaortic balloon counterpulsation as an adjunct to reperfusion therapy in cardiogenic shock. 
  • The use of intraaortic balloon counterpulsation in acute myocardial infarction and high risk coronary angioplasty. 
  • The use of intraaortic balloon pumping as an adjunct to reperfusion therapy in acute myocardial infarction. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. 
  • Thrombolysis and counterpulsation to improve survival in myocardial infarction complicated by hypotension and suspected cardiogenic shock or heart failure: results of the TACTICS Trial. 
  • Thrombolysis plus aortic counterpulsation: improved survival in patients who present to community hospitals with cardiogenic shock. 
  • Trends in emergency coronary artery bypass grafting after percutaneous coronary intervention, 1994-2003. 
  • Trends in intraaortic balloon counterpulsation complications and outcomes in cardiac surgery. 
  • Use of Temporary Mechanical Circulatory Support for Management of Cardiogenic Shock Before and After the United Network for Organ Sharing Donor Heart Allocation System Changes. 
  • Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction. Results of a randomized trial. The Randomized IABP Study Group. 
  • Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I Study. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. 
  • Usefulness of Intra-aortic Balloon Pump Counterpulsation. 
  • Variation in perioperative vasoactive therapy in cardiovascular surgical care: data from the Society of Thoracic Surgeons. 
• 

  Keywords of People

  • O'Connor, Christopher Michael, Adjunct Professor in the Department of Medicine, Medicine, Clinical Pharmacology